Nature Search

Resolving intervalley gaps and many-body resonances in moiré superconductors

This study of magic-angle twisted trilayer graphene moiré superconductors using scanning tunnelling microscopy and spectroscopy identifies two energy gaps that develop from many-body resonance in this highly tunable class of materials.

Hyunjin Kim
Gautam Rai
Stevan Nadj-Perge
Research04 Feb 2026
Nature

Volume: 650, P: 592-598
Frustrated charge density wave and quasi-long-range bond-orientational order in the magnetic kagome FeGe

The mechanism of the multiple-q charge density wave phase in the antiferromagnetic kagome metal FeGe is not fully understood. Here the authors reveal dimerization-driven hexagonal charge-diffuse precursor and identify the fraction of dimerized/undimerized states as the key order parameter of the phase transition.

D. Subires
A. Kar
S. Blanco-Canosa
ResearchOpen Access01 May 2025
Nature Communications

Volume: 16, P: 1-11
Reply to ‘Comment on: Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizmab’

T D Papakostas
D Vavvas
L A Kim
Correspondence12 Feb 2016
Eye

Volume: 30, P: 766-767
Softening of a flat phonon mode in the kagome ScV₆Sn₆

The recently discovered charge density wave in ScV₆Sn₆ kagome metal is under intense debate. By using a combination of experimental and theoretical techniques, the authors point to the role of flat phonon mode softening and momentum-dependent electron-phonon coupling in the formation of the charge density wave.

A. Korshunov
H. Hu
S. Blanco-Canosa
ResearchOpen Access20 Oct 2023
Nature Communications

Volume: 14, P: 1-8
Response to Comment on: Treatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA

S Nghiem-Buffet
S Baillif
A Sodi
Correspondence24 Feb 2017
Eye

Volume: 31, P: 1113-1114
Comment on: ‘Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab’

D Călugăru
M Călugăru
Correspondence04 Mar 2016
Eye

Volume: 30, P: 896-897
Aflibercept in persistent neovascular AMD: comparison of different treatment strategies in switching therapy

D Călugăru
M Călugăru
Correspondence07 Oct 2016
Eye

Volume: 31, P: 162
Aflibercept in diabetic macular edema: evaluating efficacy as a primary and secondary therapeutic option

D Călugăru
M Călugăru
Correspondence04 Nov 2016
Eye

Volume: 31, P: 342
Treatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA

D Călugăru
M Călugăru
Correspondence17 Mar 2017
Eye

Volume: 31, P: 1112-1113
Comment on: ‘Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizumab’

D Călugăru
M Călugăru
Correspondence12 Feb 2016
Eye

Volume: 30, P: 766
Comment on ‘The Royal College of Ophthalmologists Guidelines on retinal vein occlusions: executive summary’

D Călugăru
M Călugăru
Correspondence30 Oct 2015
Eye

Volume: 29, P: 1631-1632
Patterns of ranibizumab and aflibercept treatment of central retinal vein occlusion in routine clinical practice in the USA

D Călugăru
M Călugăru
Correspondence15 May 2015
Eye

Volume: 29, P: 1113
Comment on: 'Combination of peripheral laser photocoagulation with intravitreal bevacizumab in naive eyes with macular edema secondary to CRVO: prospective randomized study'

D Călugăru
M Călugăru
Correspondence10 Jun 2016
Eye

Volume: 30, P: 1520-1521
Comment on: ‘Central retinal vein occlusion: modifying current treatment protocols’

D Călugăru
M Călugăru
Correspondence22 Apr 2016
Eye

Volume: 30, P: 1395-1396

Search

Filter By:

Search

Quick links